Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

Fintel reports that on May 16, 2025, Jones Trading downgraded their outlook for Oncolytics Biotech (NasdaqCM:ONCY) from Buy ...

MAIA Biotechnology, Inc.’s MAIA share price has surged by 11.93%, which has investors questioning if this is right time to sell.

I traveled to the iconic Asilomar Conference Grounds in Monterey Bay as one of 50 “Next Generation Leaders” invited to take ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy ...

Vir Biotechnology VIR is set to give its latest quarterly earnings report on Wednesday, 2025-05-07. Here's what investors need to know before the announcement. Analysts estimate that Vir ...

After reports of his appointment, the S&P Biotech ETF extended losses, tumbling more than 6%. FDA Commissioner Marty Makary informed staff of the hire in a Tuesday email obtained by STAT ...

Pennsylvania-based Windtree Therapeutics is an unlikely new entrant in the city's multifamily scene, purchasing a 436-unit property in Houston as it attempts to diversify its holdings. The drug ...

This cutting-edge field represents the convergence of artificial intelligence, sensor technology, and biotechnology. For investors looking beyond the quarterly hype cycle, this emerging sector ...

Shenzhen Genocury Biotech Co., Ltd. is a clinical-stage biotechnology pioneer redefining in vivo cell engineering through its proprietary Vivoexpress™ platform. This modular delivery system ...

Oversupply and demand dampened by a pullback in venture capital have plagued biotech landlords for more than a year, causing steep increases in vacancy in even the top life sciences markets.

Legault said he was happy that Canada had a prime minister with an economic background, saying Carney had impressed him in their encounters. He said they shared a desire to invest in the ...